Genetic polymorphisms of ADH1B, ADH1C and ALDH2 have been reported involving in the development and progression of many cancers, such as gastric cancer (41), head and neck cancers (42), esophageal cancer (43), and pancreatic cancer (44). This evidence concerns the gene ADH1B and pancreatic neoplasm.